HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrokeratodermia Variabilis

An autosomal dominant skin disease characterized by transient and variable noninflammatory ERYTHEMA and hyperkeratosis. It has been associated with mutations in the genes that code for CONNEXINS. Erythrokeratodermia variabilis inherited in an autosomal recessive fashion has also been reported. Affected individuals often develop PALMOPLANTAR KERATODERMA.
Also Known As:
Erythro et Keratodermia Variabilis; Erythrokeratodermia Figurata, Congenital Familial, in Plaques; Erythrokeratodermia Variabilis with Erythema Gyratum Repens; Erythrokeratodermia, Progressive Symmetric; Transgrediens et Progrediens Palmoplantar Keratoderma; Progressive Symmetric Erythrokeratodermia; Erythrokeratodermia Figurata Variabilis; Greither Disease; Mendes De Costa Syndrome
Networked: 57 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hearing Loss (Hearing Impairment)
2. Ichthyosis (Xeroderma)
3. Deafness (Deaf Mutism)
4. Skin Diseases (Skin Disease)
5. Psoriasis (Pustulosis Palmaris et Plantaris)

Experts

1. Pan, Qian: 4 articles (11/2015 - 06/2005)
2. Lin, Zhimiao: 2 articles (11/2022 - 01/2019)
3. Wang, Huijun: 2 articles (11/2022 - 01/2019)
4. Chi, Jingwei: 2 articles (11/2015 - 01/2012)
5. Liu, Mujun: 2 articles (11/2015 - 01/2012)
6. Tang, Chengyuan: 2 articles (11/2015 - 01/2012)
7. Wang, Danling: 2 articles (11/2015 - 01/2012)
8. Zhang, Zhuohua: 2 articles (11/2015 - 01/2012)
9. Cai, Fang: 2 articles (08/2005 - 06/2005)
10. Liu, Yu: 2 articles (08/2005 - 06/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Erythrokeratodermia Variabilis:
1. AcitretinFDA Link
2. RetinoidsIBA
3. EtretinateFDA Link
4. ConnexinsIBA
5. human GJB3 proteinIBA
6. connexin 30.3IBA
7. Connexin 43 (Connexin43)IBA
8. Vitamin A (Retinol)FDA LinkGeneric
9. Proteins (Proteins, Gene)FDA Link
10. EnzymesIBA

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Therapeutics
3. Radiotherapy
4. Palliative Care (Palliative Therapy)